These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24326134)
1. A study on the properties and reactivity of naphthoquinone-cobalt(III) prototypes for bioreductive prodrugs. Bustamante FL; Miranda FS; Castro FA; Resende JA; Pereira MD; Lanznaster M J Inorg Biochem; 2014 Mar; 132():37-44. PubMed ID: 24326134 [TBL] [Abstract][Full Text] [Related]
2. Lawsone dimerization in cobalt(III) complexes toward the design of new prototypes of bioreductive prodrugs. Bustamante FL; Metello JM; de Castro FA; Pinheiro CB; Pereira MD; Lanznaster M Inorg Chem; 2013 Feb; 52(3):1167-9. PubMed ID: 23343393 [TBL] [Abstract][Full Text] [Related]
6. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins. Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553 [TBL] [Abstract][Full Text] [Related]
7. Iron(III) complexes of tripodal monophenolate ligands as models for non-heme catechol dioxygenase enzymes: correlation of dioxygenase activity with ligand stereoelectronic properties. Mayilmurugan R; Visvaganesan K; Suresh E; Palaniandavar M Inorg Chem; 2009 Sep; 48(18):8771-83. PubMed ID: 19694480 [TBL] [Abstract][Full Text] [Related]
8. Iron(III) complexes of sterically hindered tetradentate monophenolate ligands as functional models for catechol 1,2-dioxygenases: the role of ligand stereoelectronic properties. Velusamy M; Mayilmurugan R; Palaniandavar M Inorg Chem; 2004 Oct; 43(20):6284-93. PubMed ID: 15446874 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of 5-hydroxy-1,4-naphthoquinone-cobalt(III) complexes for hypoxia-activated drug delivery. de Mello MVP; Cebrián-Torrejón G; Pereira JR; Dos Santos Moreira C; Gomes CBSMR; da Rocha DR; de Souza Fagundes EM; Ferreira GB; Lanznaster M J Inorg Biochem; 2019 Oct; 199():110756. PubMed ID: 31299378 [TBL] [Abstract][Full Text] [Related]
10. Azido- and chlorido-cobalt complex as carrier-prototypes for antitumoral prodrugs. Pires BM; Giacomin LC; Castro FA; Cavalcanti Ados S; Pereira MD; Bortoluzzi AJ; Faria RB; Scarpellini M J Inorg Biochem; 2016 Apr; 157():104-13. PubMed ID: 26881993 [TBL] [Abstract][Full Text] [Related]
11. Novel iron(III) complexes of tripodal and linear tetradentate bis(phenolate) ligands: close relevance to intradiol-cleaving catechol dioxygenases. Velusamy M; Palaniandavar M; Gopalan RS; Kulkarni GU Inorg Chem; 2003 Dec; 42(25):8283-93. PubMed ID: 14658880 [TBL] [Abstract][Full Text] [Related]
12. Investigation of cobalt(iii)-triazole systems as prototypes for hypoxia-activated drug delivery. de Souza IC; Faro LV; Pinheiro CB; Gonzaga DT; da Silva Fde C; Ferreira VF; Miranda Fda S; Scarpellini M; Lanznaster M Dalton Trans; 2016 Sep; 45(35):13671-4. PubMed ID: 27488398 [TBL] [Abstract][Full Text] [Related]
13. Metal-complex assemblies constructed from the flexible hinge-like ligand H2bhnq: structural versatility and dynamic behavior in the solid state. Yamada K; Yagishita S; Tanaka H; Tohyama K; Adachi K; Kaizaki S; Kumagai H; Inoue K; Kitaura R; Chang HC; Kitagawa S; Kawata S Chemistry; 2004 Jun; 10(11):2647-60. PubMed ID: 15195296 [TBL] [Abstract][Full Text] [Related]
14. Cross-bridged cyclen or cyclam Co(III) complexes containing cytotoxic ligands as hypoxia-activated prodrugs. Chang JY; Lu GL; Stevenson RJ; Brothers PJ; Clark GR; Botting KJ; Ferry DM; Tercel M; Wilson WR; Denny WA; Ware DC Inorg Chem; 2013 Jul; 52(13):7688-98. PubMed ID: 23773210 [TBL] [Abstract][Full Text] [Related]
15. Switching on oxygen activation by cobalt complexes of pentadentate ligands. Vad MS; Nielsen A; Lennartson A; Bond AD; McGrady JE; McKenzie CJ Dalton Trans; 2011 Oct; 40(40):10698-707. PubMed ID: 21866283 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, magnetic properties, and phosphoesterase activity of dinuclear cobalt(II) complexes. Daumann LJ; Comba P; Larrabee JA; Schenk G; Stranger R; Cavigliasso G; Gahan LR Inorg Chem; 2013 Feb; 52(4):2029-43. PubMed ID: 23374019 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure, spectra and reactivity of iron(III) complexes of facially coordinating and sterically hindering 3N ligands as models for catechol dioxygenases. Sundaravel K; Dhanalakshmi T; Suresh E; Palaniandavar M Dalton Trans; 2008 Dec; (48):7012-25. PubMed ID: 19050788 [TBL] [Abstract][Full Text] [Related]
19. Heteroscorpionate-based Co2+, Zn2+, and Cu2+ complexes: coordination behavior, aerobic oxidation, and hydrogen sulfide detection. Strianese M; Milione S; Bertolasi V; Pellecchia C; Grassi A Inorg Chem; 2011 Feb; 50(3):900-10. PubMed ID: 21214208 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of some novel CoII and CoIII complexes by tribochemical reactions using KI with some derivatives of thiosemicarbazide complexes derived from Girard's T and P. Al-Ashqar SM; Mostafa MM Spectrochim Acta A Mol Biomol Spectrosc; 2008 Dec; 71(4):1321-6. PubMed ID: 18534903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]